Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Precancerous Conditions 1 Papillomavirus Infections 1 Papilloma 1 Lung Neoplasms 1 Laryngeal papillomatosis 1 Keratosis, Actinic 1 Hyperthermia 1 HIV Infections 1 Cicatrix 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Anus Neoplasms 1 Acquired Immunodeficiency Syndrome 1

Interventions

Trastuzumab 243 Paclitaxel 193 Cyclophosphamide 158 Docetaxel 134 Letrozole 113 Capecitabine 113 Fulvestrant 106 Doxorubicin 103 Bevacizumab 87 Carboplatin 81 exemestane 80 Anastrozole 79 Lapatinib 70 Tamoxifen 69 Albumin-Bound Paclitaxel 57 palbociclib 54 pertuzumab 53 Taxes 51 Gemcitabine 50 Radiotherapy 46 eribulin 43 pembrolizumab 41 Everolimus 41 Ado-Trastuzumab Emtansine 41 Vinorelbine 38 130-nm albumin-bound paclitaxel 35 ixabepilone 32 Epirubicin 28 pegfilgrastim 25 liposomal doxorubicin 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Breast Neoplasms × Laser Therapy × Clear all

NCT00960154 2013-01-08

PRECISE

Medtronic Surgical Technologies

Phase NA Terminated

50 enrolled 5 charts

Hyperthermia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡